• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性皮肤坏死性嗜酸性血管炎。

Recurrent cutaneous necrotising eosinophilic vasculitis.

机构信息

Departments of, Dermatology, Taichung Veterans General Hospital, Taichung, Taiwan.

Department of, Pathology, Taichung Veterans General Hospital, Taichung, Taiwan.

出版信息

Australas J Dermatol. 2021 Feb;62(1):e102-e106. doi: 10.1111/ajd.13451. Epub 2020 Sep 25.

DOI:10.1111/ajd.13451
PMID:32975813
Abstract

Recurrent cutaneous necrotising eosinophilic vasculitis (RCNEV) is a rare disease that was first described in 1994. We report a case of RCNEV treated with corticosteroid, and 18 cases that we identified in the literature. Our review of the literature shows that RCNEV was frequently identified in middle-aged females from Asia and usually presents as erythematous to purpuric papuloplaques, angio-oedema on the extremities, as well as peripheral eosinophilia. Histopathologically, RCNEV is characterised by exclusively eosinophilic infiltration around the vascular plexus, the absence of leukocytoclasis and fibrinoid degeneration of vascular walls. Although, RCNEV responds to corticosteroid treatment, relapses have occurred during dose tapering. We also discuss the mechanisms of vascular destruction, the differential diagnosis and steroid-sparing therapies for RCNEV.

摘要

复发性皮肤坏死性嗜酸性血管炎(RCNEV)是一种罕见的疾病,于 1994 年首次描述。我们报告了一例接受皮质类固醇治疗的 RCNEV 病例,并对文献中的 18 例病例进行了回顾。我们对文献的回顾表明,RCNEV 常见于来自亚洲的中年女性,通常表现为红斑至瘀斑性丘疹、四肢血管性水肿,以及外周血嗜酸性粒细胞增多。组织病理学上,RCNEV 的特征是仅在血管丛周围有嗜酸性粒细胞浸润,没有白细胞碎裂和血管壁纤维蛋白样变性。尽管 RCNEV 对皮质类固醇治疗有反应,但在剂量逐渐减少时会复发。我们还讨论了血管破坏的机制、RCNEV 的鉴别诊断和类固醇节省疗法。

相似文献

1
Recurrent cutaneous necrotising eosinophilic vasculitis.复发性皮肤坏死性嗜酸性血管炎。
Australas J Dermatol. 2021 Feb;62(1):e102-e106. doi: 10.1111/ajd.13451. Epub 2020 Sep 25.
2
Indomethacin for recurrent cutaneous necrotizing eosinophilic vasculitis.吲哚美辛治疗复发性皮肤坏死性嗜酸性血管炎。
J Med Assoc Thai. 2007 Jun;90(6):1180-2.
3
Clinical, Dermoscopic and Histologic Features of Recurrent Cutaneous Eosinophilic Vasculitis Cases.复发性皮肤嗜酸性粒细胞性血管炎病例的临床、皮肤镜及组织学特征
Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):590-596. doi: 10.1016/j.ad.2017.12.012. Epub 2018 Jun 21.
4
Recurrent cutaneous eosinophilic vasculitis presenting as annular urticarial plaques.表现为环状荨麻疹斑块的复发性皮肤嗜酸性血管炎
Acta Derm Venereol. 2005;85(4):380-1. doi: 10.1080/00015550510030113.
5
Eosinophilic vasculitis syndrome: recurrent cutaneous eosinophilic necrotizing vasculitis.嗜酸性血管炎综合征:复发性皮肤嗜酸性坏死性血管炎。
Semin Dermatol. 1995 Jun;14(2):106-10. doi: 10.1016/s1085-5629(05)80005-7.
6
A case of refractory eosinophilic fasciitis with eosinophilic vasculitis.一例伴有嗜酸性血管炎的难治性嗜酸性筋膜炎
Eur J Dermatol. 2016 Jun 1;26(3):319-20. doi: 10.1684/ejd.2016.2760.
7
An unusual cause of vascular purpura: recurrent cutaneous eosinophilic necrotizing vasculitis.血管性紫癜的一种罕见病因:复发性皮肤嗜酸性坏死性血管炎。
Acta Derm Venereol. 2000 Sep-Oct;80(5):394-5.
8
Cutaneous eosinophilic vasculitis associated with rheumatoid arthritis.与类风湿关节炎相关的皮肤嗜酸性血管炎
Br J Dermatol. 1999 Apr;140(4):754-5.
9
A case of recurrent cutaneous eosinophilic vasculitis: successful adjuvant therapy with suplatast tosilate.复发性皮肤嗜酸性血管炎1例:用甲苯磺酸舒普拉特成功进行辅助治疗。
Br J Dermatol. 2003 Oct;149(4):901-3. doi: 10.1046/j.1365-2133.2003.05568.x.
10
Recurrent cutaneous necrotizing eosinophilic vasculitis: a case report and review of the literature.复发性皮肤坏死性嗜酸性血管炎:病例报告及文献复习。
Diagn Pathol. 2013 Nov 7;8:185. doi: 10.1186/1746-1596-8-185.

引用本文的文献

1
Pruritic Palpable Purpura on the Lower Legs: A Quiz.小腿部瘙痒性可触及性紫癜:一则病例问答
Acta Derm Venereol. 2023 Sep 14;103:adv18366. doi: 10.2340/actadv.v103.18366.
2
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.新冠疫情时代的皮肤血管炎和血管病
Front Med (Lausanne). 2022 Aug 23;9:996288. doi: 10.3389/fmed.2022.996288. eCollection 2022.